UBS O'Connor’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,334
| Closed | -$744K | – | 295 |
|
|
2024
Q4 | $744K | Buy |
8,334
+1,507
| +22% | +$135K | 0.02% | 247 |
|
|
2024
Q3 | $572K | Sell |
6,827
-273
| -4% | -$22.9K | 0.01% | 327 |
|
|
2024
Q2 | $547K | Sell |
7,100
-7,700
| -52% | -$593K | 0.02% | 353 |
|
|
2024
Q1 | $1.01M | Sell |
14,800
-4,985
| -25% | -$341K | 0.03% | 269 |
|
|
2023
Q4 | $1.14M | Sell |
19,785
-31,607
| -62% | -$1.83M | 0.04% | 249 |
|
|
2023
Q3 | $2.71M | Buy |
51,392
+10,000
| +24% | +$528K | 0.05% | 188 |
|
|
2023
Q2 | $2.24M | Sell |
41,392
-4,616
| -10% | -$250K | 0.05% | 272 |
|
|
2023
Q1 | $2.3M | Buy |
+46,008
| New | +$2.3M | 0.05% | 291 |
|
|
2022
Q4 | – | Sell |
-70,005
| Closed | -$2.71M | – | 56 |
|
|
2022
Q3 | $2.71M | Sell |
70,005
-63,000
| -47% | -$2.44M | 0.03% | 468 |
|
|
2022
Q2 | $4.96M | Buy |
+133,005
| New | +$4.96M | 0.05% | 329 |
|
|
2015
Q1 | – | Sell |
-24,302
| Closed | -$322K | – | 693 |
|
|
2014
Q4 | $322K | Buy |
+24,302
| New | +$322K | 0.01% | 534 |
|